This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Gilead US trademark lawsuit over illegally imported Biktarvy survives early challenge

By Nick Robertson ( April 21, 2025, 22:05 GMT | Insight) -- A US judge in Maryland denied a motion to dismiss Gilead Sciences' claims of trademark infringement, unfair competition and conspiracy against Gregory Santulli, personally, in connection with his operation of two companies accused of importing gray market Biktarvy from Turkey. Judge Julie Rubin said Gilead adequately pled that Santulli is the “moving force” behind an “international infringement scheme” which saw US patients’ prescriptions filled with foreign-made Gilead-branded medications.Gregory Santulli must face a trademark infringement lawsuit filed by Gilead Sciences over illegally imported medications, a US District of Maryland judge ruled Friday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections